Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 23, n. 1, 2022. DOI: 10.7175/fe.v23i1.1532. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1532. Acesso em: 29 oct. 2025.